References
- Ramsden CE, Zamora D, Leelarthaepin B et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 346, e8707 (2013).▪▪ Key study suggesting high linoleic acid intake without a concurrent increase in n‑3 polyunsaturated fatty acids may have negative outcomes.
- Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr. 93(5), 950–962 (2011). ▪ Documents changes in dietary fat sources and consumption of fatty acids from 1909 to 1999 in the USA.
- Harris WS, Mozaffarian D, Rimm E et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119(6), 902–907 (2009).
- Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 7(3), e1000252 (2010). ▪▪ Meta‑analysis indicating that n‑6 polyunsaturated fatty acid‑specific interventions may increase coronary heart disease risk and death.
- Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br. J. Nutr. 104(11), 1586–1600 (2010). ▪▪ Meta‑analysis indicating the benefits of replacing saturated fat with polyunsaturated fat.
- Woodhill JM, Palmer AJ, Leelarthaepin B, McGilchrist C, Blacket RB. Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Adv. Exp. Med. Biol. 109, 317–330 (1978).
- National Cholesterol Education Program, NIH. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106(25), 3143–3421 (2002).
- Johnson GH, Fritsche K. Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. J. Acad. Nutr. Diet 112(7), 1029–1041 (2012).
- Serhan CN. The resolution of inflammation: the devil in the flask and in the details. FASEB J. 25(5), 1441–1448 (2011). ▪ Background on oxylipins and their roles in the various stages of inflammation.
- Quehenberger O, Armando AM, Brown AH et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51(11), 3299–3305 (2010).
- Psychogios N, Hau DD, Peng J et al. The human serum metabolome. PLoS ONE 6(2), e16957 (2011).
- Ramsden CE, Ringel A, Feldstein AE et al. Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prost. Leukot. Essent. Fatty Acids 87(4–5), 135–141 (2012).